sphingosine-1-phosphate

  1. SNT Gatchaman

    Review Erythrocytes as a Source of Exerkines, 2025, Misiti et al.

    Erythrocytes as a Source of Exerkines Exercise activates many metabolic and signaling pathways in skeletal muscle and other tissues and cells, causing numerous systemic beneficial metabolic effects. Traditionally recognized for their principal role in oxygen (O2) transport, erythrocytes have...
    • SNT Gatchaman
    • Thread
    • atp bdnf ccl2 erythrocyte deformability exercise exerkine extracellular vesicles hif-1 histone lactate lactylation micro-rna nitric oxide red blood cell deformability red blood cells sphingosine-1-phosphate tgf-beta tlr-9
    • Replies: 1
    • Forum: Other health news and research
  2. SNT Gatchaman

    Review A research perspective on sphingolipid metabolism and myalgic encephalomyelitis/chronic fatigue syndrome, 2025, Xiao, Junhua

    A research perspective on sphingolipid metabolism and myalgic encephalomyelitis/chronic fatigue syndrome Xiao, Junhua No abstract. Link | PDF (Neural Regeneration Research)
  3. SNT Gatchaman

    Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder, 2024, Lingampelly, Naviaux et al.

    Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder Lingampelly, Sai Sachin; Naviaux, Jane C.; Heuer, Luke S.; Monk, Jonathan M.; Li, Kefeng; Wang, Lin; Haapanen, Lori; Kelland, Chelsea A.; Van de Water, Judy; Naviaux, Robert K. Classical...
    • SNT Gatchaman
    • Thread
    • atp autism autism spectrum disorder cell danger response ceramide cholesterol lactate mitochochria naviaux neurodevelopmental purinergic signaling sphingolipids sphingosine-1-phosphate
    • Replies: 6
    • Forum: Other health news and research
  4. Andy

    Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment, 2022, Squillace et al

    Cancer-related cognitive impairment (CRCI) is a major neurotoxicity affecting more than 50% of cancer survivors. The underpinning mechanisms are mostly unknown, and there are no FDA-approved interventions. Sphingolipidomic analysis of mouse prefrontal cortex and hippocampus, key sites of...
Back
Top Bottom